Publications by authors named "Michael Halank"

Claim this Profile
S
Survival in patients with chronic thromboembolic pulmonary hypertension treated with riociguat other medications: a COMPERA analysis.
Matthias Held, Christine Pausch, Doerte Huscher, David Pittrow, Michael Halank

ERJ Open Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis.
Athiththan Yogeswaran, Paul M Hassoun, Khaled Saleh, Meike Fünderich, Aparna Balasubramanian, Michael Halank

Am J Respir Crit Care Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Treatment Algorithm of Pulmonary Arterial Hypertension].
Ekkehard Grünig, Katrin Milger, Albert Omlor, Andreea Florea, Benjamin Egenlauf, Michael Halank

Pneumologie· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pulmonary Hypertension Associated with Lung Diseases].
Athiththan Yogeswaran, Dirk Skowasch, Vasile Foris, Finn Wilkens, Katarina Zeder, Michael Halank

Pneumologie· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Chronic Thromboembolic Pulmonary Hypertension].
Christoph B Wiedenroth, Olympia Bikou, Simone von Bonin, Michael Halank, Matthias Held

Pneumologie· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative respiratory training with incentive spirometry for the prevention of pulmonary complications after liver surgery- a randomized pilot trial (PreSpi Trial).
Esther Giehl-Brown, Henriette Rangnick, Johannes Schweipert, Michael Halank, Dirk Koschel

Langenbecks Arch Surg· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registry.
Khodr Tello, Marion Delcroix, Christine Pausch, Doerte Huscher, David Pittrow, Michael Halank

J Heart Lung Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mono and combination therapies in pulmonary arterial hypertension patients with comorbidities: A COMPERA analysis.
Dirk Skowasch, Christine Pausch, Doerte Huscher, David Pittrow, Judith Wede, Michael Halank

ESC Heart Fail· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Jérôme Michel Defosse, Vera von Dossow, Wojciech Dudek, Michael Halank, Torsten Loop

Zentralbl Chir· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Presurgical evaluation of adult thorax-surgery patients with oncologically resectable tumours - a joint recommendation of DGAI, DGT and DGP].
Jerome Defosse, Vera von Dossow, Wojciech Dudek, Michael Halank, Torsten Loop

Pneumologie· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Combination drug therapy in pulmonary hypertension: switch from selexipaq to intravenous trepostinil].
Alexander Heine, Anne Obst, Christian F Opitz, Michael Halank, Manuel Richter

Pneumologie· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study.
Marius M Hoeper, Britta Oerke, Max Wissmüller, Hanno Leuchte, Christian Opitz, Michael Halank

Circulation· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenic SMAD6 variants in patients with idiopathic and complex congenital heart disease associated pulmonary arterial hypertension.
Sofia Karl, Ekkehard Grünig, Memoona Shaukat, Matthias Held, Christian Apitz, Michael Halank

NPJ Genom Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study.
Marius M Hoeper, Britta Oerke, Max Wissmüller, Hanno Leuchte, Christian Opitz, Michael Halank

Circulation· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Air travel in patients suffering from pulmonary hypertension-A prospective, multicentre study.
Athiththan Yogeswaran, Jan Grimminger, Khodr Tello, Lukas Becker, Werner Seeger, Michael Halank

Pulm Circ· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.
Felix Gerhardt, Eva Fiessler, Karen M Olsson, Moritz Z Kayser, Gabor Kovacs, Michael Halank

Circulation· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis.
Oliver Distler, Christian Ofner, Dörte Huscher, Suzana Jordan, Silvia Ulrich, Michael Halank

Rheumatology (Oxford)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypes and treatment outcomes in idiopathic pulmonary arterial hypertension patients with comorbidities.
Dirk Skowasch, Hans Klose, Ralf Ewert, Heinrike Wilkens, Manuel Richter, Michael Halank

ERJ Open Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The new European Guidelines for Pulmonary Hypertension with Updated Commentary of the PH-DACH Conference - A position paper of the German Society for Pneumology and Respiratory Medicine (DGP)].
Ekkehard Grünig, Nicola Benjamin, Jürgen Behr, Dirk Skowasch, Katrin Milger-Kneidinger, Michael Halank

Pneumologie· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Medication treatment in pulmonary arterial hypertension with comorbidities - Which phenotypes and points to consider].
Ekkehard Grünig, Michael Halank, Claus Neurohr, Jürgen Behr, Katrin Milger-Kneidinger

Pneumologie· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pulmonary hypertension associated with lung disease].
Michael Halank, Katarina E Zeder, Natascha Sommer, Silvia Ulrich, Matthias Held

Pneumologie· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Chronic thromboembolic pulmonary hypertension].
Stefan Guth, Heinrike Wilkens, Michael Halank, Matthias Held, Lukas Hobohm

Pneumologie· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating microRNAs predict recurrence and death following venous thromboembolism.
Vincent Ten Cate, Steffen Rapp, Andreas Schulz, Alejandro Pallares Robles, Kerstin Jurk, Michael Halank

J Thromb Haemost· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil.
Pavel Jansa, Grzegorz Kopeć, Adam Torbicki, Roela Sadushi-Kolici, Ioana-Alexandra Campean, Michael Halank

Pulm Circ· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is iron deficiency caused by mutations or dysfunction in pulmonary arterial hypertension patients?
Vivienne Theobald, Ekkehard Grünig, Nicola Benjamin, Hans-Jürgen Seyfarth, Michael Halank

Pulm Circ· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis